Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant Grant D. MacLeanMark ReddishB. Michael Longenecker Original articles Pages: 215 - 222
T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens Peter A. LandoMikael DohlstenTerje Kalland Original articles Pages: 223 - 228
Cure of mice bearing a late-stage, highly metastatic, drug-resistant tumor by adoptive chemoimmunotherapy Maribeth LaudeKatherine L. RussoSheldon Dray Original articles Pages: 229 - 236
Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan fromLarix occidentalis Jochen HauerF. Alfred Anderer Original articles Pages: 237 - 244
Induction of antitumor L3T4-positive T cells by OK-432 at tumor sites in mice Yoichiro MoriyaHideki SatoNakao Ishida Original articles Pages: 245 - 250
Cellular and cytokine responses of the human central nervous system to intracranial administration of tumor necrosis factor α for the treatment of malignant gliomas Mitsuhiro TadaYutaka SawamuraHiroshi Abe Original articles Pages: 251 - 259
Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3 So OhtaAyumi HondaNobuo Hanai Original articles Pages: 260 - 266
Phase I trial of chimeric (human-mouse) monoclonal antibody L6 in patients with non-small-cell lung, colon, and breast cancer Gary E. GoodmanIngegerd HellstromKarl Erik Hellstrom Original articles Pages: 267 - 273
Monoclonal antibody uptake in B-cell lymphomas: Experimental studies in nude mouse xenografts Jörg SchmidPeter MöllerSiegfried Matzku Original articles Pages: 274 - 280